John Maher

John Maher

Company: Leucid Bio

Job title: Chief Scientific Officer


Development of TGF-b Conditioned Gamma Delta T-Cells for Immunotherapy of Cancer 3:00 pm

• TGFb enhances the yield and anti-tumour activity of ex vivo expanded circulating gamma delta T-cells • Trafficking of these cells to bone marrow is enhanced, enabling more effective treatment of haematological malignancies • Combined use of genetic enhancement approaches and regional delivery can be used to effectively target these cells against solid tumoursRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.